Jazz Pharmaceuticals SVP Patricia Carr reports sale of 1,413 shares
JAZZ•Jazz Pharmaceuticals SVP and Chief Accounting Officer Patricia Carr sold 1,413 ordinary shares on Nov. 4, 2026, and exercised options for 1,250 shares. She directly owned 6,512 ordinary shares and 3,000 non-qualified stock options after the transactions.
1. Transactions reported
Carr sold 1,250 shares at $231.37 each and 163 shares at $231.27 each on Nov. 4, 2026. She also exercised non-qualified stock options for 1,250 ordinary shares at $140.03 each that day.
2. Holdings after transactions
Following the transactions, Carr directly owned 6,512 ordinary shares and 3,000 non-qualified stock options. The Form 4 was signed Nov. 6, 2026.
